Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.

Current drug safety

Volumn 3, Issue 2, 2008, Pages 154-162

  Strombom, Indiana ^a   Wernicke, Joachim F ^a   Seeger, John ^a   D'Souza, Deborah N ^a   Acharya, Nayan ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; CYCLOHEXANOL DERIVATIVE; DULOXETINE; SEROTONIN UPTAKE INHIBITOR; THIOPHENE DERIVATIVE; VENLAFAXINE;

ARTICLE; CHEMICALLY INDUCED DISORDER; DATA BASE; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; LIVER; LIVER DISEASE; RISK ASSESSMENT; SAFETY; UNITED STATES;

ADRENERGIC UPTAKE INHIBITORS; ADVERSE DRUG REACTION REPORTING SYSTEMS; CONSUMER PRODUCT SAFETY; CYCLOHEXANOLS; DATABASES AS TOPIC; HUMANS; LIVER; LIVER DISEASES; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS; THIOPHENES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 66749083239     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488608784529215     Document Type: Article

References (0)